Seo DH et al., 2024-05-07: Korean 2024 biochemistry paper from the Korea Basic Science Institute on how methylene blue induces disulfide-bond formation in tubulin-associated proteins, part of the mechanistic work behind leuco-methylthioninium (LMTM) for Alzheimer's disease.
Mechanism of Methylene Blue Inducing the Disulfide Bond Formation of Tubulin-Associated Unit Proteins.
2451-2455
Seo DH et al., 2024-05-07: Korean 2024 biochemistry paper from the Korea Basic Science Institute on how methylene blue induces disulfide-bond formation in tubulin-associated proteins, part of the mechanistic work behind leuco-methylthioninium (LMTM) for Alzheimer's disease. C4 Korea. Study type: in-vitro protein biochemistry, no patients. The abstract states that methylene blue recently completed a Phase 3 trial as leuco-methylthioninium bis(hydromethanesulfonate) for Alzheimer's disease – a statement about a trial, not a result. Funding: Korea Basic Science Institute per affiliations; paper-level conflicts not captured. Mechanism work, not clinical evidence. Study type: lab.
